Libby Znaimer is joined by Dr. Malcolm Moore, a medical oncologist, Princess Margaret Cancer Centre and Dr. Alisa Naiman, family physician as well as founder and medical director of The Medical Station in Toronto and John Papastergiou, a pharmacist at Shoppers Drug Mart.

Today: a discussion about new clinical trial data that indicates that it is safe to stop immunotherapy after two years if a patient with lung cancer is "progression-free". In other news: patients with a certain type of brain tumor may soon be able to get an oral treatment that would serve as an alternative to radiation and chemotherapy. And, in Ottawa, the federal NDP have tabled a pharmacare bill to implement a universal single-payer pharmacare system in Canada. Our panel weighs in on the latest.

ARBITRATION RULING FOR HEALTHCARE WORKERS

Libby Znaimer is joined by Sharleen Stewart, President of SEIU Healthcare.

An arbitration ruling has granted 45,000 healthcare workers in the province with a 6.25 per cent wage increase. Sharleen provides more details on what this means for front line workers in the province.

----

BONNIE CROMBIE IS OFFICIALLY RUNNING FOR LEADER OF ONTARIO LIBERALS

Libby Znaimer is now joined by Bob Richardson, Liberal Strategist and Senior Council to National Public Relations, and John Mykytyshyn, a conservative strategist and President of Bradgate Research Group.

It's official: Bonnie Crombie has announced that she's running for leadership of the Ontario Liberals. Interestingly, a poll by Abacus Data shows Bonnie being the front runner but the same poll shows that Doug Ford's PC government would be re-elected if elections were held right now. So, what does her entry into the race mean for the future of the party?

Listen live, weekdays from noon to 1, on Zoomer Radio!